— Gevo Inc. (NASDAQ: GEVO) reported a third-quarter 2019 adjusted loss of $0.66 per share versus a loss of $0.55 per share expected.
— Total revenues fell by 29% to $6.11 million versus $4.77 million expected. The results were hurt by lower ethanol sales.
— Revenues derived at the Luverne Facility related to ethanol sales and related products fell by 31% due to reduced production of ethanol and distiller grains as a result of unfavorable commodity environment.
— Hydrocarbon revenues increased by 9% helped by higher production volumes at the South Hampton Resources Inc. facility in Silsbee, Texas.
— Research and development expenses declined by 4% due primarily to a decrease in costs associated with its South Hampton Facility partially offset by an increase in personnel and consultant expenses.
— Gevo believes it can become profitable, or close to it, as a company by the end of 2021 if Gevo can successfully improve the carbon footprint of its Luverne Facility.
— Gevo expects one or more of its renewable natural gas projects that are under development to come on-line by the end of 2020 or early 2021, adding to its EBITDA in 2021.
BlackBerry Limited (NYSE: BB) is slated to report its fourth-quarter 2020 earnings results on Tuesday, March 31, after the market closes. The top line will be benefited by BlackBerry Cylance
The coronavirus pandemic continues to plague the world with over 500,000 cases reported globally and over 82,000 cases in the US alone. As the world grapples with the outbreak, several
Altimmune Inc. (NASDAQ: ALT) reported its earnings results for fiscal-year 2019. Revenues totaled $5.8 million compared to $10.3 million last year. The drop in revenues was caused by lower billings